An in-depth understanding of the mechanisms underlying EndMT or the acquisition of a
profibrotic secretory phenotype by endothelial cells will provide the rationale for novel …

Idiopathic pulmonary fibrosis is a progressive and incurable lung disease characterized by
collagen deposition, alveolar inflammation, fibroblast proliferation, and the destruction of …

COVID-19 prognoses suggests that a proportion of patients develop fibrosis, but there is no
evidence to indicate whether patients have progression of mesenchymal transition (MT) in …

Lungs are constantly exposed to environmental perturbations and therefore have
remarkable capacity to regenerate in response to injury. Sustained lung injuries, aging, and …

Pulmonary fibrosis (PF) is a progressive and chronic lung disease characterized by
excessive extracellular matrix (ECM) deposition and fibroblast proliferation. Endothelial-to …

Introduction: Chronic lung disorders involve pathological alterations in the lung tissue with
hypoxia as a consequence. Hypoxia may influence the release of inflammatory mediators …

SARS-CoV-2 infection can manifest as a wide range of respiratory and systemic symptoms
well after the acute phase of infection in over 50% of patients. Key questions remain on the …

Extract We sincerely appreciate the correspondence from SS Sohal, whose recent
discoveries in human pulmonary fibrosis [1, 2] are complementary to our report on an …

Sarcoidosis has been a well-recognised risk factor for pulmonary hypertension (PH) for a
long time, but still, the knowledge about this concatenation is incomplete. Sarcoidosis …

Extract I read with great interest the recent original research article by Wu et al.[1] published
in the prestigious European Respiratory Journal (ERJ), which reported on endothelial cell …